NLRP3 and diabetic kidney disease: This observation is consistent with prior reports in other pathological contexts, including diabetic nephropathy [24] and epilepsy [25], where curcumin has been shown to effectively inhibit NLRP3 activity, thereby strengthening its potential as a widely applicable anti-inflammatory and antioxidant agent.